Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy

Currently interferon alfa-2b (IFNα-2b) is an approved adjuvant drug for high-risk melanoma patients that leads to an improvement in disease-free survival (DFS). However, it is unclear whether it also impacts overall survival. Widespread use of adjuvant high-dose IFNα has been tempered by its signifi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Kaehler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Haalck, Thomas, Heinzerling, Lucie, Kornek, Thomas, Livingstone, Elisabeth, Loquai, Carmen, Maul, Lara Valeska, Lang, Berenice M., Schadendorf, Dirk, Stade, Barbara, Terheyden, Patrick, Utikal, Jochen, Wagner, Tobias, Hauschild, Axel, Garbe, Claus, Augustin, Matthias
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2016
Fag:
5700
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120927/
https://ncbi.nlm.nih.gov/pubmed/27861370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005375
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker